loader image

QUANTUM - DRIVEN THERANOSTICS PLATFORM

ACADEMY OVERVIEW

QUANTALPHA ACADEMY FOR THERANOSTICS

Theranostics, or Radiomolecular Precision Oncology, represents a paradigm shift in cancer care today. World-class standardized education of healthcare professionals is key to ensure sustainable patient access on a global scale. The QUANTALPHA Academy for Theranostics offers a comprehensive online educational program, developed by the QUANTALPHA Foundation and powered by its global community of experts. The main objective of the QUANTALPHA Academy program is to disseminate knowledge in Theranostics to improve the outcomes of patients and quality of care treated with radiopharmaceuticals therapies.

ACCREDITATION & ENDORSEMENT

The ICPO Academy for Theranostics is accredited by the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), with UEMS-EACCME ® certification ensuring internationally recognized CME credits. After successful completion, the learners receive a certificate from ICPO and if applicable also one from UEMS. Moreover, many regional and national nuclear medicine societies have endorsed the ICPO Academy for Theranostics.

Accreditations

Endorsements

CURRICULUM

ICPO Academy learners have the opportunity to acquire fundamental knowledge and expertise in Radiomolecular Precision Oncology, Medical Physics, Radio Chemistry and Nursing and Patient Management. Each Teaching Unit takes about 45 minutes to complete. The units contain 2-3 teaching videos, each about 10-15 minutes long, and may offer additional teaching content such as videos and links to external videos, animations, interviews and further readings.

50+ VIDEOS

30+ EXPERTS

10+ LANGUAGES

TARGET AUDIENCE

Lead Faculty

Drawing on deep expertise and a strong commitment to advancing patient-centered Theranostics, all Faculty of the ICPO Academy for Theranostics structure and deliver a comprehensive e-learning content, guiding participants through the fundamental pillars of Theranostics and preparing them to successfully integrate these principles into clinical practice.

Prof. Richard P. Baum

Prof. Richard P. Baum

President of the ICPO ACADEMY FOR THERANOSTICS

Prof. Vikas Prasad

Prof. Vikas Prasad

Prof. Thomas Beyer

Prof. Thomas Beyer

Prof. Vikas Prasad

Prof. Vikas Prasad

Prof. Vikas Prasad

Prof. Vikas Prasad

Prof. Thomas Beyer

Prof. Thomas Beyer

RADIOMOLECULAR PRECISION ONCOLOGY (RPO) PILLAR

RADIOMOLECULAR PRECISION ONCOLOGY (RPO) PILLAR

RADIOCHEMISTRY (RC) PILLAR

RADIOCHEMISTRY (RC) PILLAR

MEDICAL PHYSICS (MP) PILLAR

MEDICAL PHYSICS (MP) PILLAR

NURSING AND PATIENT MANAGEMENT (NP) PILLAR

NURSING AND PATIENT MANAGEMENT (NP) PILLAR

Apply and get access

The Academy for Theranostics has been designed to widen accessibility to education and to scale worldwide. While no pre-requirements are set, the content is particularly tailored to provide fundamental knowledge and a continued learning opportunity to healthcare professionals specializing in nuclear medicine and oncology-related specialties as well as medical students. There are 3 options to apply and get access:

  • N
    Industry sponsored stipend
  • N
    Invited guest by QUANTALPHA Partners
  • N
    Self-Payer

The ICPO team will review your application and provide login credentials as well as encourage you to progress through the Teaching Units and complete certification, ideally with a couple of months.

TESTIMONIALS

“Collaborating with the ICPO Foundation, our theranostics center is leading a transformative shift toward precision oncology in South Africa. As an ICPO Theranostics Clinical Center, we benefit from the global community and exchange with world-class experts within the foundation.”

Prof. Mike Sathekge,

CEO of Nuclear Medicine Research Infrastructure Univ. of Pretoria, South Africa
“Collaborating with the ICPO Foundation, our theranostics center is leading a transformative shift toward precision oncology in South Africa. As an ICPO Theranostics Clinical Center, we benefit from the global community and exchange with world-class experts within the foundation.”

Prof. Mike Sathekge,

CEO of Nuclear Medicine Research Infrastructure Univ. of Pretoria, South Africa
“Collaborating with the ICPO Foundation, our theranostics center is leading a transformative shift toward precision oncology in South Africa. As an ICPO Theranostics Clinical Center, we benefit from the global community and exchange with world-class experts within the foundation.”

Prof. Mike Sathekge,

CEO of Nuclear Medicine Research Infrastructure Univ. of Pretoria, South Africa